FDA is to give approval on ‘Female Viagra’ in late August.

pill

After being rejected twice, the “female viagra” (flibanserin) has resurfaced and this time it looks like it may be here to stay.

Is the drug effective?

The effect of flibanserin is described “modest.” In company studies, women taking flibanserin reported a slight increase in sexually satisfying events each month. Their answers to separate questionnaires indicated they experienced a slight increase in desire and a slight decrease in stress.

While FDA scientists describe these effects as “small,” they were significant enough to meet FDA effectiveness standards.

The FDA panelists acknowledged this week that flibanserin will not help all patients. The percentage of patients reporting positive results with flibanserin was only 10 to 15 percent higher than among patients taking a placebo. That suggests as few as 1 in 10 patients may actually benefit from the drug, according to some FDA advisers.

Overall, the drug got positive voting 18-6 vote in favor of approval to become the first medication indicated for premenopausal women with Hypoactive Sexual Desire Disorder (HSDD).

Read more about on New Haven Register Health

Share